We present a clinimetric assessment of the Movement Disorder Society (MDS)‐sponsored
revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS). The MDS‐UDPRS …

This article presents the revision process, major innovations, and clinimetric testing program
for the Movement Disorder Society (MDS)–sponsored revision of the Unified Parkinson's …

Parkinson disease (PD) is an age-related neurodegenerative disorder that affects as many
as 1–2% of persons aged 60 years and older. With the aging of the population, the frequency …

Objective To determine the frequency and correlates of impulse control disorders (ICDs) in
Parkinson disease (PD). Design An unstructured screening interview for ICDs (compulsive …

Objectives: To examine the effect of depression and other nonmotor symptoms on functional
ability in Parkinson's disease (PD). Design: A cross‐sectional study of a convenience …

Mitochondrial (mt) impairment, particularly within complex I of the electron transport system,
has been implicated in the pathogenesis of Parkinson disease (PD). More than half of …

OBJECTIVES: To examine Montreal Cognitive Assessment (MoCA) performance in patients
with Parkinson's disease (PD) with “normal” global cognition according to Mini‐Mental State …

As no comprehensive assessment instrument for impulse control disorders (ICDs) in Parkinson's
disease (PD) exists, the aim of this study was to design and assess the psychometric …

Decreased olfactory function is among the first signs of idiopathic Parkinson's disease (PD).
Whether such dysfunction is present to the same degree on both sides of the nose, however, …

Object. Deep brain stimulation (DBS) has been advocated as a more highly effective and
less morbidity-producing alternative to ablative stereotactic surgery in the treatment of …